Yuka Kitamura

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma

Principles and therapeutic applications of adaptive immunity

Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma

Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3